A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

The Phase II trial will assess the therapy’s safety, tolerability and its activity across various biomarkers in IPF patients.

More information: Jimmy Tsz Hang Lee et al, Integrated histopathology, spatial and single cell transcriptomics resolve ...

Modelling and Life and Health at the University of Bonn have presented their €100,000 research prize, entitled “Modelling for ...

Tobacco-based products, including e-cigarettes, have gained popularity as perceived safer alternatives to traditional smoking despite their addictive nature. However, emerging evidence shows that ...

The patients’ cells, however, were unresponsive to CCL-2 and meandered ... the researchers found a decreased number of alveolar macrophages in their patients’ bronchoalveolar lavage samples. These ...